Side-by-side comparison of AI visibility scores, market position, and capabilities
Subscription management platform taken private at $1.7B by Silver Lake/GIC Oct 2024; $419.9M ARR at 103% NRR with 451 enterprise customers competing with Chargebee and Stripe Billing for subscription billing automation.
Zuora, Inc. is a Redwood City, California-based subscription management and billing platform — taken private in October 2024 in a $1.7 billion acquisition by Silver Lake and GIC (Singapore's sovereign wealth fund) at $10/share (formerly NYSE: ZUO) — providing SaaS companies, IoT manufacturers, media publishers, and enterprises transitioning to recurring revenue models with quote-to-cash automation, usage-based billing, revenue recognition compliance, and subscription analytics. At the time of acquisition, Zuora had $419.9 million in ARR (+6% year-over-year), 451 large enterprise customers, and a 103% net revenue retention rate — metrics that validated the subscription business management platform's unit economics for Silver Lake's private market value creation thesis.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.